Readers And Tweeters: Doctors Chime In On Telemedicine Costs
Posted onKaiser Health News gives readers a chance to comment on a recent batch of stories.
Tag: FDA
Important safety information for certain respirator masks
Posted onHealth Canada is committed to ensuring that the medical devices available to Canadians meet the necessary safety and effectiveness standards. The Department has contactedcompanies that may be importing or distributing certain respirators, including KN95 respirators, that may not meet expected performance standards in Canada to request that they stop sale and relabel the products as face masks instead of respirators.
Expedited access to household cleaning products, hand soaps and body soaps to help fight COVID-19
Posted onIn light of the unprecedented demand and urgent need for products that can help fight COVID-19—including household cleaning products, hand soaps and body soaps—as an interim policy, Health Canada is facilitating access to products that may not fully meet current regulatory requirements.
Health Canada updates Canadians on its ongoing assessment of nitrosamine impurities in certain drugs
Posted onOTTAWA – Health Canada has beenworkingto address the issue of N-nitrosodimethylamine (NDMA) and similar nitrosamine impurities found in certain “sartan” angiotensin receptor blocker (ARB) blood pressure medications since 2018 and, certain ranitidine drugs more recently.
Update on the potential risk of pulmonary illness associated with vaping products
Posted onSeptember 6, 2019
Information Update – Health Canada warns of potential risk of pulmonary illness associated with vaping products
Posted onOTTAWA – Health Canada is advising Canadians who use vaping products to monitor themselves for symptoms of pulmonary illness (e.g., cough, shortness of breath, chest pain) and to seek medical attention promptly if they have concerns about their health.
Addiction Clinics Market Pricey, Unproven Treatments To Desperate Patients
Posted onAn amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
MDMA, Or Ecstasy, Shows Promise As A PTSD Treatment
Posted onMDMA, the psychoactive ingredient in the club drug known as molly or ecstasy, is being tested in combination with therapy as a treatment for severe trauma.
FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine
Posted onIn March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity
Posted onAffected products The following products containing Losartan manufactured by Hetero Labs Ltd. Unit 1 are being recalled. Health Canada maintains a complete list of sartan drugs that have been recalled because of nitrosamine impurities on its website.